Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barjat

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Biomedicines|April 23, 2022
Animal Models of Chorioamnionitis: Considerations for Translational MedicineTiphaine Raia-Barjat, Margaux Digonnet, Antoine Giraud, et al.
La Revue De Medecine Interne|April 20, 2024
[Systematic analysis of evaluations of Objective Structured Clinical Exam (OSCE) multiple circuits: Explanatory variables and inter-rater correlations]E Ollier, C Pelissier, C Boissier, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|January 8, 2026
[CNGOF statement on instrumental vaginal deliveries using vacuum extraction]Jeanne Sibiude, Nicolas Mottet, Tiphaine Raia-Barjat, et al.
BMJ Open|January 27, 2026
Balloon plus oxytocin or oral misoprostol for labour induction in prelabour rupture of membranes (PROM): protocol for a randomised controlled trial (RUBAPRO2)Marion Rouzaire, Alexia Triolaire, Christophe Vayssière, et al.
Medical Oncology (Northwood, London, England)|November 23, 2014
OSNA (one-step nucleic acid amplification) sentinel lymph node intraoperative molecular analysis in breast cancer: a cost-benefit analysisTiphaine Raia-Barjat, Béatrice Trombert, Abir Khaddage, et al.
Journal of Perinatal Medicine|June 22, 2026
The cytokine Prokineticin-1 in preterm labor with and without intra-amniotic inflammationMorgane Desseux, Tiphaine Raia-Barjat, Roberto Romero, et al.
Scientific Reports|November 14, 2023
EG-VEGF maternal levels predict spontaneous preterm birth in the second and third trimesters in pregnant women with risk factors for placenta-mediated complicationsTiphaine Raia-Barjat, Céline Chauleur, Constance Collet, et al.
Developmental Medicine and Child Neurology|January 26, 2023
Perinatal inflammation exposure and developmental outcomes 7 years after neonatal arterial ischaemic strokeAntoine Giraud, Mickaël Dinomais, Pauline Garel, et al.
Plos One|August 15, 2017
The use of 18F-Fluoro-deoxy-glucose positron emission tomography (18F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active dose of AZD8835, a novel PI3Kα inhibitorJuliana Maynard, Sally-Ann Emmas, Francois-Xavier Ble, et al.
Plos One|July 14, 2017
Correction: Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred studyAurélie Di Bartolomeo, Céline Chauleur, Brigitte Tardy, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Biomedicines|April 23, 2022
Animal Models of Chorioamnionitis: Considerations for Translational MedicineTiphaine Raia-Barjat, Margaux Digonnet, Antoine Giraud, et al.
La Revue De Medecine Interne|April 20, 2024
[Systematic analysis of evaluations of Objective Structured Clinical Exam (OSCE) multiple circuits: Explanatory variables and inter-rater correlations]E Ollier, C Pelissier, C Boissier, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|January 8, 2026
[CNGOF statement on instrumental vaginal deliveries using vacuum extraction]Jeanne Sibiude, Nicolas Mottet, Tiphaine Raia-Barjat, et al.
BMJ Open|January 27, 2026
Balloon plus oxytocin or oral misoprostol for labour induction in prelabour rupture of membranes (PROM): protocol for a randomised controlled trial (RUBAPRO2)Marion Rouzaire, Alexia Triolaire, Christophe Vayssière, et al.
Medical Oncology (Northwood, London, England)|November 23, 2014
OSNA (one-step nucleic acid amplification) sentinel lymph node intraoperative molecular analysis in breast cancer: a cost-benefit analysisTiphaine Raia-Barjat, Béatrice Trombert, Abir Khaddage, et al.
Journal of Perinatal Medicine|June 22, 2026
The cytokine Prokineticin-1 in preterm labor with and without intra-amniotic inflammationMorgane Desseux, Tiphaine Raia-Barjat, Roberto Romero, et al.
Scientific Reports|November 14, 2023
EG-VEGF maternal levels predict spontaneous preterm birth in the second and third trimesters in pregnant women with risk factors for placenta-mediated complicationsTiphaine Raia-Barjat, Céline Chauleur, Constance Collet, et al.
Developmental Medicine and Child Neurology|January 26, 2023
Perinatal inflammation exposure and developmental outcomes 7 years after neonatal arterial ischaemic strokeAntoine Giraud, Mickaël Dinomais, Pauline Garel, et al.
Plos One|August 15, 2017
The use of 18F-Fluoro-deoxy-glucose positron emission tomography (18F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active dose of AZD8835, a novel PI3Kα inhibitorJuliana Maynard, Sally-Ann Emmas, Francois-Xavier Ble, et al.
Plos One|July 14, 2017
Correction: Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred studyAurélie Di Bartolomeo, Céline Chauleur, Brigitte Tardy, et al.
Pageof 10